# Patient-centered, Optimal Integration of Survivorship and Palliative Care

> **NCT04900935** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Stage IV Non-small Cell Lung Cancer
- Targeted Therapy
- Nonsmall Cell Lung Cancer
- Carcinoma, Non-Small-Cell Lung
- ALK-positive Non-small Cell Lung Cancer
- EGFR Positive Non-small Cell Lung Cancer
- Palliative Care
- Survivorship

## Interventions

- **BEHAVIORAL:** POISE

## Key facts

- **NCT ID:** NCT04900935
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-29
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04900935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04900935, "Patient-centered, Optimal Integration of Survivorship and Palliative Care". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04900935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*